Table 5.
EXT | INT | FH | ETD | PUG | NUG | Age | SES | GA | AS Acc | |
---|---|---|---|---|---|---|---|---|---|---|
SUBCORTICAL | ||||||||||
CaudateL.R. | −1.36 | −0.41 | −1.03 | 0.04 | −1.00 | 1.55 | −1.65 | −0.47 | 0.41 | 2.48* |
PutamenL.R. | −2.29 | −1.24 | −1.33 | −0.19 | −4.68*B,C,G | −1.35 | 0.87 | −0.30 | 0.44 | 3.08* |
NAccL.R. | −1.38 | −0.21 | 0.06 | 0.45 | 1.39 | 1.68 | −0.86 | 0.70 | 0.81 | −0.14 |
CORTICAL | ||||||||||
PPCL.R. | −0.91 | −0.33 | −2.74+B,C | −2.42 | −0.51 | −0.20 | 0.10 | −0.58 | 0.64 | 1.72 |
FEFL.R. | −2.05 | −0.79 | −0.78 | 0.20 | −2.64*B,C,G | −0.87 | 1.03 | 0.23 | 2.09 | 2.34+ |
SEF | −1.45 | −0.63 | −0.23 | 0.89 | −1.06 | −0.75 | −0.34 | −0.77 | −0.55 | 2.04+ |
Pre-SMA | −1.79 | 0.25 | −0.26 | −1.22 | −1.70 | −1.88 | 0.34 | 0.06 | 0.84 | 2.14+ |
dACC | −1.53 | −0.54 | −0.88 | −0.55 | −1.59 | −0.93 | −0.94 | −0.30 | 1.11 | 2.57* |
DLPFCL.R. | −0.36 | −0.10 | −1.51 | −1.25 | −1.65 | −0.12 | −1.34 | −0.62 | −1.46 | 0.49 |
VLPFCL.R. | −0.90 | −1.31 | −1.04 | 0.07 | −1.34 | −0.64 | 1.35 | −1.28 | 0.47 | −1.21 |
IFGL.R. | 0.43 | −0.48 | −1.47 | −0.80 | −3.00*B,C,G | −0.26 | −0.05 | −1.03 | −1.31 | 1.16 |
p < 0.10 (corrected),
p < 0.05 (corrected). Displayed estimates are test statistics from models with the specific factor, subject age, visit, and reward condition (Type A).
p < 0.05 (Type B) model with all risk factors, subject age, visit, and reward condition;
p < 0.05 (Type C) model with all risk factors, subject age, visit, reward condition, and SES and GA.
Positive Urgency p < 0.05 while covarying gender.
, Left/Right ROIs are included within one model. Estimates with uncorrected p's < 0.05 are bolded.